PatentsGlobal
Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment
Patents bolster Genprex’s global IP portfolio, supporting ongoing Acclaim-3 clinical trial for small cell lung cancer with PD-L1 and PD-1 antibody combinations
Genprex, Inc. has obtained favorable patent grants from the Japanese Patent Office and European Patent Office covering the use of its REQORSA gene therapy in combination with PD-L1 and PD-1 antibodies to treat cancer. These patents reinforce Genprex’s intellectual property rights in major markets and underpin its Accl…